B10.82 Human herpesvirus 7 infection

Name of the Condition

• Human herpesvirus 7 infection

Summary

Human herpesvirus 7 (HHV-7) infection is caused by the HHV-7 virus, a member of the Herpesviridae family. The infection can present with diverse clinical manifestations, ranging from mild, self-limiting illnesses to severe, systemic disease. Primary infection often occurs in early childhood and may be asymptomatic or associated with febrile illness. Reactivation can occur in immunocompromised individuals, leading to more serious complications.

Causes

Human herpesvirus 7 infection is caused by the HHV-7 virus, which is transmitted through direct contact with infected bodily fluids, respiratory droplets, or vertical transmission (e.g., from mother to fetus). The virus establishes lifelong latency in host cells after primary infection and may reactivate under conditions of immunosuppression.

Risk Factors

• Immunocompromised states, such as HIV/AIDS, organ transplantation, or chemotherapy.
• Primary infection in young children.
• Reactivation in individuals with weakened immune systems.

Symptoms

• Febrile illness, particularly in infants (e.g., roseola infantum).
• Rash, often after fever subsides.
• Lymphadenopathy.
• In immunocompromised patients, potential for severe complications like encephalitis or pneumonitis.

Diagnosis

Diagnosis of HHV-7 infection is typically based on clinical presentation and laboratory testing. Serologic tests can detect antibodies to HHV-7, while molecular methods (e.g., PCR) may identify viral DNA in blood or tissue samples. Differentiation from other herpesviruses (e.g., HHV-6) is important for accurate diagnosis.

Treatment Options

Treatment for HHV-7 infection is generally supportive, focusing on symptom relief (e.g., antipyretics for fever). In immunocompromised patients or those with severe complications, antiviral therapy (e.g., ganciclovir, foscarnet) may be considered, though specific efficacy data for HHV-7 is limited.

Prognosis and Follow-Up

Most primary HHV-7 infections resolve without long-term sequelae. In immunocompetent individuals, prognosis is excellent. Immunocompromised patients may experience prolonged or recurrent infections, requiring close monitoring for complications. Follow-up depends on clinical severity and immune status.

Complications

• Encephalitis or meningitis (rare, more common in immunocompromised hosts).
• Pneumonitis or respiratory distress.
• Exacerbation of underlying conditions in immunocompromised patients.

Lifestyle & Prevention

• Practice good hygiene (e.g., handwashing) to reduce transmission risk.
• Avoid close contact with individuals showing active infection symptoms.
• Immunocompromised individuals should follow precautions to minimize exposure to viral pathogens.

When to Seek Professional Help

Seek medical attention if symptoms worsen (e.g., high fever, persistent rash, neurological changes) or if you have a weakened immune system and suspect infection. Prompt evaluation is important for severe or atypical presentations.

Tips for Medical Coders

Use code B10.82 for documented human herpesvirus 7 infection. Ensure clinical documentation supports the diagnosis, including laboratory confirmation or compatible symptoms. Differentiate from other herpesvirus infections (e.g., HHV-6) to avoid coding errors.